Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial

N. Peters; H. Morley; S. Khalique; S. Scalzo; R. Patel; U. Gunaydin; G. Funingana; J. Evans; D. Papadatos-Pastos; U. Banjeri; B. Basu; A. Niewiarowski; S. Symeonides; F. Kelly; L. Sawretse; C. Bacon; M. Robinson; T. Gelb; S. Blakemore; N. Cook

doi:10.1016/S0959-8049(22)01114-5

Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial

N. Peters, H. Morley, S. Khalique, S. Scalzo, R. Patel, U. Gunaydin, G. Funingana, J. Evans, D. Papadatos-Pastos, U. Banjeri, B. Basu, A. Niewiarowski, S. Symeonides, F. Kelly, L. Sawretse, C. Bacon, M. Robinson, T. Gelb, S. Blakemore, N. Cook

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S117-S118
Journal	European Journal of Cancer
Volume	174
Early online date	28 Oct 2022
DOIs	https://doi.org/10.1016/S0959-8049(22)01114-5
Publication status	Published - 28 Oct 2022

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0959-8049(22)01114-5

Cite this

Peters, N., Morley, H., Khalique, S., Scalzo, S., Patel, R., Gunaydin, U., Funingana, G., Evans, J., Papadatos-Pastos, D., Banjeri, U., Basu, B., Niewiarowski, A., Symeonides, S., Kelly, F., Sawretse, L., Bacon, C., Robinson, M., Gelb, T., Blakemore, S., & Cook, N. (2022). Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial. European Journal of Cancer, 174, S117-S118. https://doi.org/10.1016/S0959-8049(22)01114-5

@article{0f78e54f9d494e07b665014fb0c09efd,

title = "Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial",

author = "N. Peters and H. Morley and S. Khalique and S. Scalzo and R. Patel and U. Gunaydin and G. Funingana and J. Evans and D. Papadatos-Pastos and U. Banjeri and B. Basu and A. Niewiarowski and S. Symeonides and F. Kelly and L. Sawretse and C. Bacon and M. Robinson and T. Gelb and S. Blakemore and N. Cook",

year = "2022",

month = oct,

day = "28",

doi = "10.1016/S0959-8049(22)01114-5",

language = "English",

volume = "174",

pages = "S117--S118",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier BV",

}

Peters, N, Morley, H, Khalique, S, Scalzo, S, Patel, R, Gunaydin, U, Funingana, G, Evans, J, Papadatos-Pastos, D, Banjeri, U, Basu, B, Niewiarowski, A, Symeonides, S, Kelly, F, Sawretse, L, Bacon, C, Robinson, M, Gelb, T, Blakemore, S & Cook, N 2022, 'Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial', European Journal of Cancer, vol. 174, pp. S117-S118. https://doi.org/10.1016/S0959-8049(22)01114-5

TY - JOUR

T1 - Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial

AU - Peters, N.

AU - Morley, H.

AU - Khalique, S.

AU - Scalzo, S.

AU - Patel, R.

AU - Gunaydin, U.

AU - Funingana, G.

AU - Evans, J.

AU - Papadatos-Pastos, D.

AU - Banjeri, U.

AU - Basu, B.

AU - Niewiarowski, A.

AU - Symeonides, S.

AU - Kelly, F.

AU - Sawretse, L.

AU - Bacon, C.

AU - Robinson, M.

AU - Gelb, T.

AU - Blakemore, S.

AU - Cook, N.

PY - 2022/10/28

Y1 - 2022/10/28

UR - http://www.scopus.com/inward/record.url?scp=85140442256&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(22)01114-5

DO - 10.1016/S0959-8049(22)01114-5

M3 - Article

AN - SCOPUS:85140442256

SN - 0959-8049

VL - 174

SP - S117-S118

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial

Research Beacons, Institutes and Platforms

UN SDGs

Access to Document

Other files and links

Cite this